Immuron Ltd
immuron.com.auWhat Do They Do?
Sells Travelan, an oral product for reducing travelers’ diarrhea, to pharmacy and online retail customers; also sells ProIBS for IBS symptoms and develops oral antibody drug candidates for infectious diseases.
20-F for FY2026, filed Sep 24, 2026We are a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and…View ↗
Following the rapid growth of Travelan in pharmacies as a leading product for the prevention of traveler’s diarrhea, we launched ProIBS® to…View ↗
We currently have two lead drug candidates entering the clinical development phase, which we believe have the potential to transform the…View ↗
Who Are Their Customers?
In Australia, Travelan is sold through retail pharmacies with outside sales support; in Canada, it is sold through pharmacies and grocery stores via a service provider. In the United States, Immuron sells directly to Passport Health Travel Clinics and through distributors, Amazon.com and Walmart.com, with online orders on consignment.
20-F for FY2026, filed Sep 24, 2026For our marketing efforts, we engage external resources which work with our in-house marketing team, with our approach to marketing varying…View ↗
How Are They Changing?
Product portfolio
The earlier report lists Travelan and Protectyn as Australian products; the latest adds ProIBS and says Protectyn was removed from the Australian Register of Therapeutic Goods.
20-F for FY2023, filed Sep 28, 2023 20-F for FY2026, filed Sep 24, 2026We are a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and…View ↗
Loading...
